Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans

被引：117

作者：

Cagigi, Alberto ^{[1
]}

Lore, Karin ^{[1
]}

机构：

[1] Karolinska Inst, Karolinska Univ Hosp, Dept Med Solna, Div Immunol & Allergy, S-16164 Solna, Sweden

来源：

VACCINES | 2021年 / 9卷 / 01期

基金：

瑞典研究理事会;

关键词：

mRNA vaccine; dendritic cell; protein translation; type I interferon; Th1; polarization; antibody response; SARS-CoV-2; ANTIGEN-PRESENTING CELLS; T-CELL; IN-VIVO; LIPID NANOPARTICLES; H7N9; INFLUENZA; VACCINES; DELIVERY; PROTECTION; INDUCTION; POTENT;

D O I：

10.3390/vaccines9010061

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In this concise review, we summarize the concepts behind mRNA vaccination. We discuss the innate and adaptive immune response generated by mRNA vaccines in different animal models and in humans. We give examples of viral infections where mRNA vaccines have shown to induce potent responses and we discuss in more detail the recent SARS-CoV-2 mRNA vaccine trials in humans.

引用

页码：1 / 14

页数：14

共 84 条

[1] mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials [J].

A Feldman, Robert ;

Fuhr, Rainard ;

Smolenov, Igor ;

Ribeiro, Amilcar ;

Panther, Lori ;

Watson, Mike ;

Senn, Joseph J. ;

Smith, Mike ;

Almarsson, Orn ;

Pujar, Hari S. ;

Laska, Michael E. ;

Thompson, James ;

Zaks, Tal ;

Ciaramella, Giuseppe .

VACCINE, 2019, 37 (25) :3326-3334

[2] Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms [J].

Akinc, Akin ;

Querbes, William ;

De, Soma ;

Qin, June ;

Frank-Kamenetsky, Maria ;

Jayaprakash, K. Narayanannair ;

Jayaraman, Muthusamy ;

Rajeev, Kallanthottathil G. ;

Cantley, William L. ;

Dorkin, J. Robert ;

Butler, James S. ;

Qin, LiuLiang ;

Racie, Timothy ;

Sprague, Andrew ;

Fava, Eugenio ;

Zeigerer, Anja ;

Hope, Michael J. ;

Zerial, Marino ;

Sah, Dinah W. Y. ;

Fitzgerald, Kevin ;

Tracy, Mark A. ;

Manoharan, Muthiah ;

Koteliansky, Victor ;

de Fougerolles, Antonin ;

Maier, Martin A. .

MOLECULAR THERAPY, 2010, 18 (07) :1357-1364

[3] Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial [J].

Alberer, Martin ;

Gnad-Vogt, Ulrike ;

Hong, Henoch Sangjoon ;

Mehr, Keyvan Tadjalli ;

Backert, Linus ;

Finak, Greg ;

Gottardo, Raphael ;

Bica, Mihai Alexandru ;

Garofano, Aurelio ;

Koch, Sven Dominik ;

Fotin-Mleczek, Mariola ;

Hoerr, Ingmar ;

Clemens, Ralf ;

von Sonnenburg, Frank .

LANCET, 2017, 390 (10101) :1511-1520

[4] A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption [J].

Allard, Sabine D. ;

De Keersmaecker, Brenda ;

de Goede, Anna L. ;

Verschuren, Esther J. ;

Koetsveld, Jeanette ;

Reedijk, Mariska L. ;

Wylock, Carolien ;

De Bel, Annelies V. ;

Vandeloo, Judith ;

Pistoor, Frank ;

Heirman, Carlo ;

Beyer, Walter E. P. ;

Eilers, Paul H. C. ;

Corthals, Jurgen ;

Padmos, Iman ;

Thielemans, Kris ;

Osterhaus, Albert D. M. E. ;

Lacor, Patrick ;

van der Ende, Marchina E. ;

Aerts, Joeri L. ;

van Baalen, Carel A. ;

Gruters, Rob A. .

CLINICAL IMMUNOLOGY, 2012, 142 (03) :252-268

[5] Duration of humoral immunity to common viral and vaccine antigens [J].

Amanna, Ian J. ;

Carlson, Nichole E. ;

Slifka, Mark K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (19) :1903-1915

[6] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults [J].

Anderson, E. J. ;

Rouphael, N. G. ;

Widge, A. T. ;

Jackson, L. A. ;

Roberts, P. C. ;

Makhene, M. ;

Chappell, J. D. ;

Denison, M. R. ;

Stevens, L. J. ;

Pruijssers, A. J. ;

McDermott, A. B. ;

Flach, B. ;

Lin, B. C. ;

Doria-Rose, N. A. ;

O'Dell, S. ;

Schmidt, S. D. ;

Corbett, K. S. ;

Swanson, P. A., II ;

Padilla, M. ;

Neuzil, K. M. ;

Bennett, H. ;

Leav, B. ;

Makowski, M. ;

Albert, J. ;

Cross, K. ;

Edara, V. V. ;

Floyd, K. ;

Suthar, M. S. ;

Martinez, D. R. ;

Baric, R. ;

Buchanan, W. ;

Luke, C. J. ;

Phadke, V. K. ;

Rostad, C. A. ;

Ledgerwood, J. E. ;

Graham, B. S. ;

Beigel, J. H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2427-2438

[7] Type I interferon dependence of plasmacytoid dendritic cell activation and migration [J].

Asselin-Paturel, C ;

Brizard, G ;

Chemin, K ;

Boonstra, A ;

O'Garra, A ;

Vicari, A ;

Trinchieri, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07) :1157-1167

[8] Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns [J].

Bachmann, Martin F. ;

Jennings, Gary T. .

NATURE REVIEWS IMMUNOLOGY, 2010, 10 (11) :787-796

[9] Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses [J].

Bahl, Kapil ;

Senn, Joe J. ;

Yuzhakov, Olga ;

Bulychev, Alex ;

Brito, Luis A. ;

Hassett, Kimberly J. ;

Laska, Michael E. ;

Smith, Mike ;

Almarsson, Orn ;

Thompson, James ;

Ribeiro, Amilcar ;

Watson, Mike ;

Zaks, Tal ;

Ciaramella, Giuseppe .

MOLECULAR THERAPY, 2017, 25 (06) :1316-1327

[10] Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response [J].

Bourquin, Carole ;

Schmidt, Laura ;

Hornung, Veit ;

Wurzenberger, Cornelia ;

Anz, David ;

Sandholzer, Nadja ;

Schreiber, Susanne ;

Voelkl, Andreas ;

Hartmann, Gunther ;

Endres, Stefan .

BLOOD, 2007, 109 (07) :2953-2960

← 1 2 3 4 5 6 7 8 9 →